The cost per human genome sequence has breached key economic thresholds, unlocking scalable deployment of precision diagnostics across public and private healthcare systems. High-throughput sequencing platforms are drastically reducing unit costs for comprehensive genomic profiling.
Early Detection via Liquid Biopsy
Decreased sequencing costs have made non-invasive liquid biopsies economically viable for routine screening. Medical centers report higher rates of early-stage cancer detection, translating to improved patient outcomes and lower long-term treatment costs for insurers.
Data Infrastructure Demands
The exponential growth of genomic data requires significant investment in secure cloud storage and computational pipelines. Health IT departments are adopting specialized bioinformatics software to process sequencing output into actionable clinical reports efficiently.